Stockreport

Why Travere Therapeutics (TVTX) Is Up 18.9% After FDA Eases FILSPARI Oversight And Delays Adcom [Yahoo! Finance]

Travere Therapeutics, Inc.  (TVTX) 
PDF FILSPARI, including the removal of an FDA advisory committee review and easing of REMS monitoring requirements ahead of a January 13, 2026 decision on a potential FSGS l [Read more]